| Ident. | Authors (with country if any) | Title |
|---|
| 004207 |
P. Anglade [France] ; S. Vyas ; F. Javoy-Agid ; M T Herrero ; P P Michel ; J. Marquez ; A. Mouatt-Prigent ; M. Ruberg ; E C Hirsch ; Yves Agid [France] | Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. |
| 004434 |
C. Gargalidis-Moudanos [France] ; N. Pizzinat ; F. Javoy-Agid ; A. Remaury ; A. Parini | I2-imidazoline binding sites and monoamine oxidase activity in human postmortem brain from patients with Parkinson's disease |
| 004439 |
S. Vyas [France] ; F. Javoy-Agid [France] ; M.-T. Herrero [Espagne] ; O. Strada [France] ; F. Boissiere [France] ; U. Hibner [France] ; Yves Agid [France] | Expression of Bcl-2 in adult human brain regions with special reference to neurodegenerative disorders |
| 004477 |
P. Anglade [France] ; V. Blanchard ; R. Raisman-Vozari ; B A Faucheux ; M T Herrero ; J A Obeso ; A. Mouatt-Prigent ; A. Kastner ; O. Strada ; F. Javoy-Agid ; Yves Agid [France] ; E C Hirsch | Is dopaminergic cell death accompanied by concomitant nerve plasticity? |
| 004619 |
M. Chritin ; V. Blanchard [France] ; R. Raisman-Vozari [France] ; C. Feuerstein ; Yves Agid [France] ; F. Javoy-Agid [France] ; M. Savasta | DA Uptake Sites, D1, and D2 Receptors, D2 and Preproenkephalin mRNAs and Fos Immunoreactivity in Rat Striatal Subregions after Partial Dopaminergic Degeneration |
| 004623 |
J. L. Pezzoli [Italie] ; O. Strada [Italie] ; V. Silani [Italie] ; A. Zecchinelli [Italie] ; L. Perbellini [France] ; F. Javoy-Agid [Italie] ; P. Ghidoni [Italie] ; E. D. F. Motti [Italie] ; T. Masini [Italie] ; G. Scarlato [Italie] ; Yves Agid [Italie] ; E. C. Hirsch [Italie] | Clinical and pathological features in hydrocarbon‐induced Parkinsonism |
| 004658 |
J. Guridi [Espagne] ; M. T. Herrero ; M. R. Luquin ; J. Guillen ; M. Ruberg ; J. Laguna ; M. Vila ; F. Javoy-Agid ; Yves Agid [France] ; E. Hirsch ; J. A. Obeso | Subthalamotomy in parkinsonian monkeys : Behavioural and biochemical analysis |
| 004674 |
M. Vila [France] ; M. T. Herrero ; R. Levy [France] ; B. Faucheux [France] ; M. Ruberg [France] ; J. Guillen ; M. R. Luquin ; J. Guridi ; F. Javoy-Agid [France] ; Yves Agid [France] ; J. A. Obeso ; E. C. Hirsch [France] | Consequences of nigrostriatal denervation on the γ-aminobutyric acidic neurons of substantia nigra pars reticulata and superior colliculus in parkinsonian syndromes |
| 004825 |
R. Levy [France] ; M. T. Herrero [France, Espagne] ; M. Ruberg [France] ; J. Villares [France] ; B. Faucheux [France] ; J. Guridi [Espagne] ; J. Guillen [Espagne] ; M. R. Luquin [Espagne] ; F. Javoy-Agid [France] ; J. A. Obeso [Espagne] ; Yves Agid [France] ; E. C. Hirsch [France] | Effects of Nigrostriatal Denervation and L‐Dopa Therapy on the GABAergic Neurons of the Striatum in MPTP‐treated Monkeys and Parkinson's Disease: An In Situ Hybridization Study of GAD67 mRNA |
| 004842 |
B. A. Faucheux [France] ; M. T. Herrero [Espagne] ; J. Villares [France] ; R. Levy [France] ; F. Javoy-Agid [France] ; J. A. Obeso [Espagne] ; J. J. Hauw [France] ; Yves Agid [France] ; E. C. Hirsch [France] | Autoradiographic localization and density of [125I]ferrotransferrin binding sites in the basal ganglia of control subjects, patients with Parkinson's disease and MPTP-lesioned monkeys |
| 004886 |
V. Blanchard [France] ; M. Chritin ; SHEELA VYAS [France] ; M. Savasta ; C. Feuerstein ; Yves Agid [France] ; F. Javoy-Agid [France] ; R. Raisman-Vozari [France] | Long-term induction of tyrosine hydroxylase expression : compensatory response to partial degeneration of the dopaminergic nigrostriatal system in the rat brain |
| 004891 |
M.-T. Herrero [Espagne] ; S. J. Augood ; E. C. Hirsch [France] ; F. Javoy-Agid [France] ; M. R. Luquin [Espagne] ; Yves Agid [France] ; J. A. Obeso [Espagne] ; P. C. Emson | Effects of L-DOPA on preproenkephalin and preprotackykinin gene expression in the MPTP-treated monkey striatum |
| 004893 |
M. Ruberg [France] ; D. Scherman [France] ; F. Javoy-Agid [France] ; Yves Agid [France] | Dopamine denervation, age on onset, and Parkinson's disease |
| 004A30 |
Chaodong Kastner [France] ; M. T. Herrero [France, Espagne] ; E. C. Hirsch [France] ; J. Guillen [Espagne] ; M. R. Luquin [Espagne] ; F. Javoy-Agid [France] ; J. A. Obeso [Espagne] ; Yves Agid [France] | Decreased tyrosine hydroxylase content in the dopaminergic neurons of MPTP–intoxicated monkeys: Effect of levodopa and GM1 ganglioside therapy |
| 004A79 |
J. Villares [France] ; O. Strada ; B. Faucheux ; F. Javoy-Agid ; Yves Agid [France] ; E. C. Hirsch | Loss of striatal affinity NGF binding sites in progressive supranuclear palsy but not in Parkinson's disease |
| 004A82 |
G. Boka [France] ; P. Anglade [France] ; D. Wallach ; F. Javoy-Agid [France] ; Yves Agid [France] ; E. C. Hirsch [France] | Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease |
| 004A87 |
A. Kastner [France] ; M. T. Herrero [France] ; E. C. Hirsch [France] ; J. Guillen ; M. R. Luquin ; F. Javoy-Agid [France] ; J. A. Obeso ; Yves Agid [France] | Decreased tyrosine hydroxylase content in the dopaminergic neurons of MPTP-intoxicated monkeys : effect of levodopa and GM1 ganglioside therpay |
| 004B04 |
F. Javoy-Agid [France] | Parkinson's Disease Brain Bank in Paris: an evolutive bank responding to the exigencies of new neurochemical methodologies. |
| 004B10 |
B A Faucheux [France] ; E C Hirsch ; J. Villares ; F. Selimi ; A. Mouatt-Prigent ; F. Javoy-Agid ; J J Hauw ; Yves Agid [France] | Distribution of 125I-ferrotransferrin binding sites in the mesencephalon of control subjects and patients with Parkinson's disease. |
| 004B63 |
A. Kastner [France] ; E. C. Hirsch [France] ; Yves Agid [France] ; F. Javoy-Agid [France] | Tyrosine hydroxylase protein and messenger RNA in the dopaminergic nigral neurons of patients with Parkinson's disease |
| 004B88 |
M. T. Herrero [France] ; E. C. Hirsch [France] ; A. Kastner [France] ; M. Ruberg [France] ; M. R. Luquin [Espagne] ; J. Laguna [Espagne] ; F. Javoy-Agid [France] ; J. A. Obeso [Espagne] ; Yves Agid [Espagne] | Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP? |
| 004B89 |
M. T. Herrero [France] ; E. C. Hirsch [France] ; F. Javoy-Agid [France] ; J. A. Obeso [Espagne] ; Yves Agid [France] | Differential vulnerability to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine of dopaminergic and cholinergic neurons in the monkey mesopontine tegmentum |
| 004C48 |
O. Strada [France] ; E. C. Hirsch [France] ; F. Javoy-Agid [France] ; C. Duyckaerts [France] ; J.-J. Hauw [France] ; Yves Agid [France] | Low affinity nerve growth factor receptor, adrenal transplant and Parkinson's disease |
| 004C53 |
A. Kastner [France] ; E. C. Hirsch ; M. T. Herrero ; F. Javoy-Agid ; Yves Agid [France] | Immunocytochemical quantification of tyrosine hydroxylase at a cellular level in the mesencephalon of control subjects and patients with Parkinson's and Alzheimer's disease |
| 004C54 |
P. Damier [France] ; E. C. Hirsch ; P. Zhang ; Yves Agid [France] ; F. Javoy-Agid | Glutathione peroxidase, glial cells and Parkinson's disease |
| 004C55 |
M.-T. Herrero [France] ; A. Kastner [France] ; I. Perez-Otano ; E. C. Hirsch [France] ; M.-R. Luquin ; F. Javoy-Agid [France] ; J. Del Rio ; J. A. Obeso ; Yves Agid [France] | Gangliosides and parkinsonism |
| 004C63 |
B. A. Faucheux [France] ; E. C. Hirsch [France] ; J. Villares [France] ; F. Selimi [France] ; A. Mouatt-Prigent [France] ; F. Javoy-Agid [France] ; J. J. Hauw [France] ; Yves Agid [France] | Distribution of 125I-ferrotransferrin binding sites in the mesencephalon of control subjects and patients with Parkinson's disease |
| 004C67 |
Yves Agid [France] ; M. Ruberg ; F. Javoy-Agid ; E. Hirsch ; R. Raisman-Vozari ; S. Vyas ; B. Faucheux ; P. Michel ; A. Kastner ; V. Blanchard ; P. Damier ; J. Villares ; PING ZHANG | Are dopaminergic neurons selectively vulnerable to Parkinson's disease ? |
| 004E38 |
A. Kastner [France] ; E. C. Hirsch ; O. Lejeune ; F. Javoy-Agid ; O. Rascol [France] ; Yves Agid [France] | Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content ? |
| 004E53 |
E C Hirsch [France] ; J P Brandel ; P. Galle ; F. Javoy-Agid ; Yves Agid [France] | Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis. |
| 004E54 |
G K Lloyd [France] ; A. Lowenthal ; F. Javoy-Agid ; J. Constantidinis | GABAA receptor complex function in frontal cortex membranes from control and neurological patients. |
| 004F03 |
D. T. Dexter [Royaume-Uni] ; A. Carayon [France] ; F. Javoy-Agid [France] ; Yves Agid [France] ; F. R. Wells [Royaume-Uni] ; S. E. Daniel [Royaume-Uni] ; A. J. Lees [Royaume-Uni] ; P. Jenner [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | ALTERATIONS IN THE LEVELS OF IRON, FERRITIN AND OTHER TRACE METALS IN PARKINSON'S DISEASE AND OTHER NEURODEGENERATIVE DISEASES AFFECTING THE BASAL GANGLIA |
| 004F96 |
E. C. Hirsch [France] ; J.-P. Brandel ; P. Galle ; F. Javoy-Agid ; Yves Agid [France] | Iron and aluminium increase in the substantia nigra of patients with Parkinson's disease : an X-ray microanalysis |
| 004F97 |
G. K. Lloyd [France] ; A. Lowenthal ; F. Javoy-Agid ; J. Constantidinis | GABAA receptor complex function in frontal cortex membranes from control and neurological patients |
| 005004 |
P. Gaspar [France] ; C. Duyckaerts [France] ; C. Alvarez ; F. Javoy-Agid ; B. Berger | Alterations of dopaminergic and noradrenergic innervations in motor cortex in Parkinson's disease |
| 005008 |
Yves Agid [France] ; A M Graybiel ; M. Ruberg ; E. Hirsch ; J. Blin ; B. Dubois ; F. Javoy-Agid | The efficacy of levodopa treatment declines in the course of Parkinson's disease: do nondopaminergic lesions play a role? |
| 005009 |
I. Ceballos [France] ; F. Javoy-Agid ; A. Delacourte ; A. Defossez ; A. Nicole ; P M Sinet | Parkinson's disease and Alzheimer's disease: neurodegenerative disorders due to brain antioxidant system deficiency? |
| 005017 |
I. Ceballos [France] ; M. Lafon [France] ; F. Javoy-Agid [France] ; E. Hirsch [France] ; A. Nicole [Royaume-Uni] ; P. M. Sinet [Royaume-Uni] ; Yves Agid [Royaume-Uni] | Superoxide dismutase and Parkinson's disease |
| 005074 |
F. Thibaut [France] ; E. C. Hirsch [France] ; R. Raisman [France] ; F. Javoy-Agid [France] ; Yves Agid [France] | Microtopography of d1 dopaminergic binding sites in the human substantia nigra: An autoradiographic study |
| 005086 |
E. C. Hirsch [France] ; C. Duyckaerts [France] ; F. Javoy-Agid [France] ; J. Hauw [France] ; Yves Agid [France] | Does adrenal graft enhance recovery of dopaminergic neurons in Parkinson's disease? |
| 005091 |
F. Javoy-Agid [France] ; E. C. Hirsch [France] ; S. Dumas [France] ; C. Duyckaerts [France] ; J. Mallet [France] ; Yves Agid [France] | Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in parkinson's disease: An in situ hybridization study |
| 005133 |
S. Dumas ; F. Javoy-Agid ; E. Hirsch ; Yves Agid [France] ; J. Mallet | Tyrosine hydroxylase gene expression in human ventral mesencephalon : detection of tyrosine hydroxylase messenger RNA in neurites |
| 005155 |
Yves Agid [France] ; P. Cervera ; E. Hirsch ; F. Javoy-Agid ; S. Lehericy ; R. Raisman ; M. Ruberg | Biochemistry of Parkinson's disease 28 years later: a critical review. |
| 005198 |
H. Taquet [France] ; F. Javoy-Agid [France] ; A. Mauborgne [France] ; J. J. Benohel [France] ; Yves Agid [France] ; F. Cesselin [France] ; M. Hamon [France] | Neuropeptides in the basal ganglia of patients with Parkinson's or Steele‐Richardson's disease |
| 005208 |
F. Javoy-Agid [France] ; B. Scatton [France] ; M. Ruberg [France] ; R. L'Heureux [France] ; P. Cervera [France] ; R. Raisman [France] ; J.-M. Maloteaux [Belgique] ; H. Beck [France] ; Yves Agid [France] | Distribution of monoaminergic, cholinergic, and GABAergic markers in the human cerebral cortex |
| 005246 |
D. Scherman ; C. Desnos ; F. Darchen ; P. Pollak ; F. Javoy-Agid ; Yves Agid [France] | Striatal dopamine deficiency in Parkinson's disease: role of aging |
| 005256 |
J. Epelbaum [France] ; F. Javoy-Agid [France] ; A. Enjalbert [France] ; S. Krantic [France] ; C. Kordon [France] ; Yves Agid [France] | Somatostatin concentrations and binding sites in human frontal cortex are differentially affected in Parkinson's disease associated dementia and in progressive supranuclear palsy |
| 005263 |
H. Taquet [France] ; M. Nomoto [Royaume-Uni] ; S. Rose [Royaume-Uni] ; P. Jenner [Royaume-Uni] ; F. Javoy-Agid [Royaume-Uni] ; A. Mauborgne [France] ; J. J. Benoliel [France] ; C. D. Marsden [Royaume-Uni] ; J. C. Legrand [France] ; Yves Agid [France] ; M. Hamon [France] ; F. Cesselin [France] | Levels of MET-enkephalin, LEU-enkephalin, substance P and cholecystokinin in the brain of the common marmoset following long term 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine treatment |
| 005311 |
Glenn M. Maloteaux [Belgique] ; E. C. Laterre [Belgique] ; P. M. Laduron [France] ; F. Javoy-Agid [France] ; Yves Agid [France] | Decrease of serotonin‐S2 receptors in temporal cortex of patients with Parkinson's disease and progressive supranuclear palsy |
| 005337 |
S. Jegou ; F. Javoy-Agid ; C. Delbende ; D. Tranchand-Bunel ; D. H. Coy ; Yves Agid [France] ; H. Vaudry | Regional distribution of vasoactive intestinal peptide in brains from normal and parkinsonian subjects |
| 005373 |
P. Delay-Goyet [France] ; J.-M. Zajac [France] ; F. Javoy-Agid [France] ; Yves Agid [France] ; B. P. Roques [France] | Regional distribution of μ, δ and κ opioid receptors in human brains from controls and parkinsonian subjects |
| 005415 |
P. Dealy-Goyet ; J.-M. Zajac ; F. Javoy-Agid ; Yves Agid [France] ; B. P. Roques | Regional distribution of μ, σ and k opioid receptors in human brains from controls and parkinsonian subjects |
| 005423 |
J. Epelbaum ; F. Javoy-Agid ; E. Hirsch ; J. J. Hauw ; C. Kordon ; S. Krantic ; Yves Agid [France] | Brain somatostatin concentrations do not decrease in progressive supranuclear palsy |
| 005478 |
Yves Agid [France] ; H. Taquet ; F. Cesselin ; J. Epelbaum ; F. Javoy-Agid | Neuropeptides and parkinson's disease |
| 005492 |
Yves Agid [France] ; F. Javoy-Agid [France] | Peptides and Parkinson's disease |
| 005518 |
H. Schoemaker [France] ; C. Pimoule [France] ; S. Arbilla [France] ; B. Scatton [France] ; F. Javoy-Agid [France] ; S. Z. Langer [France] | Sodium dependent [3H]cocaine binding associated with dopamine uptake sites in the rat striatum and human putamen decrease after dopaminergic denervation and in Parkinsons disease |
| 005521 |
L. Pique [France] ; S. Jegou [France] ; X. Bertagna [France] ; F. Javoy-Agid [France] ; D. Seurin [France] ; M. F. Proeschel [France] ; F. Girard [France] ; Yves Agid [France] ; H. Vaudry [France] ; J. P. Luton [France] | Pro-opiomelanocortin peptides in the human hypothalamus: Comparative study between normal subjects and parkinson patients |
| 005532 |
H. Taquet [France] ; F. Javoy-Agid [France] ; P. Giraud [France] ; J. C. Legrand [France] ; Yves Agid [France] ; F. Cesselin [France] | Dynorphin levels in parkinsonian patients: Leu5-enkephalin production from either proenkephalin A or prodynorphin in human brain |
| 005534 |
J. M. Allen [Royaume-Uni] ; A. J. Cross [Royaume-Uni] ; T. J. Crow [Royaume-Uni] ; F. Javoy-Agid [France] ; Yves Agid [France] ; S. R. Bloom [Royaume-Uni] | Dissociation of neuropeptide Y and somatostatin in Parkinson's disease |
| 005553 |
J. C. Monfort ; F. Javoy-Agid ; J. J. Hauw ; B. Dubois ; Yves Agid [France] | Brain glutamate decarboxylase in Parkinson's disease with particular reference to a premortem severity index |
| 005556 |
Howardi Hurtig [États-Unis] ; C. Miller Fisher [États-Unis] ; E. Ringwald [Suisse] ; M. Ruberg [France] ; F. Javoy-Agid [France] ; Yves Agid [France] | WHAT CAUSES PARKINSON'S DISEASE? |
| 005607 |
B. Bokobza ; M. Ruberg ; B. Scatton ; F. Javoy-Agid ; Yves Agid [France] | [3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy |
| 005610 |
C. Llorens-Cortes ; F. Javoy-Agid ; Yves Agid [France] ; H. Taquet ; J. C. Schwartz | Enkephalinergic markers in substantia nigra and caudate nucleus from Parkinsonian subjects |
| 005611 |
F. Javoy-Agid ; D. Grouselle ; A. Tixier-Vidal ; Yves Agid [France] | Thyrotropin releasing hormone content is unchanged in brains of patients with Parkinson disease |
| 005625 |
M. Garbarg [France] ; F. Javoy-Agid [France] ; J. C. Schwartz [France] ; Yves Agid [France] | BRAIN HISTIDINE DECARBOXYLASE ACTIVITY IN PARKINSON'S DISEASE |
| 005645 |
H. Taquet [France] ; F. Javoy-Agid [France] ; M. Hamon [France] ; J. C. Legrand [France] ; Yves Agid [France] ; F. Cesselin [France] | Parkinson's disease affects differently Met5- and Leu5-enkephalin in the human brain |
| 005652 |
A. Mauborgne [France] ; F. Javoy-Agid [France] ; J. C. Legrand [France] ; Yves Agid [France] ; F. Cesselin [France] | Decrease of substance P-like immunoreactivity in the substantia nigra and pallidum of parkinsonian brains |
| 005678 |
H. Taquet [France] ; F. Javoy-Agid [France] ; F. Cesselin [France] ; M. Hamon [France] ; J. C. Legrand [France] ; Yves Agid [France] | Microtopography of methionine-enkephalin, dopamine and noradrenaline in the ventral mesencephalon of human control and Parkinsonian brains |
| 005689 |
J. M. Studler [France] ; F. Javoy-Agid [France] ; F. Cesselin [France] ; J. C. Legrand [France] ; Yves Agid [France] | CCK-8-immunoreactivity distribution in human brain: selective decrease in the substantia nigra from parkinsonian patients |
